Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 6/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6859069 | 0.90 | ALDH1A1 (0.50) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL19455882 | 0.90 | ALDH1A1 (0.50) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL10897741 | 0.87 | ALDH1A1 (0.48) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL2452696 | 0.87 | — | — | |
| SCHEMBL2958422 | 0.86 | CYP3A4 (0.53) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL5373874 | 0.86 | TSHR (0.50) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL1682010 | 0.84 | ALDH1A1 (0.43) | ALDH1A1TSHRCYP3A4L3MBTL1FAAH | |
| SCHEMBL8349861 | 0.84 | TSHR (0.50) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL29008641 | 0.84 | CYP3A4 (0.52) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 | |
| SCHEMBL1826406 | 0.84 | TSHR (0.50) | ALDH1A1TSHRCYP3A4L3MBTL1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116375567-A | Method for manufacturing multi-branched high carbonic acid | 浙江信汇新材料股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | claimed |
| CN-116375567-B | Method for manufacturing multi-branched high carbonic acid | 浙江信汇新材料股份有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-116375567-A | Method for manufacturing multi-branched high carbonic acid | 浙江信汇新材料股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| WO-2023100719-A1 | FULLERENE DERIVATIVE, n-TYPE SEMICONDUCTOR MATERIAL, ORGANIC POWER GENERATION LAYER AND PHOTOELECTRIC CONVERSION ELEMENT | 株式会社ハーベス | 2023-06-08 | — | — | WO | disclosed |
| EP-3372581-B1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | DAIKIN IND LTD (JP) | 2021-06-23 | — | — | EP | disclosed |
| US-10894770-B2 | Fullerene derivative and n-type semiconductor material | DAIKIN INDUSTRIES, LTD. (JP) | 2021-01-19 | — | — | US | disclosed |
| US-20180282274-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | DAIKIN INDUSTRIES, LTD. (JP) | 2018-10-04 | — | — | US | disclosed |
| EP-3372581-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | Daikin Industries, Ltd. (JP) | 2018-09-12 | — | — | EP | disclosed |
| CN-108137498-A | Fullerene derivate and n-type semiconductor | 大金工业株式会社 | 2018-06-08 | — | — | CN | disclosed |
| EP-1794133-B1 | ARYL SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | MERCK SHARP & DOHME (US) | 2011-12-14 | — | — | EP | disclosed |
| EP-1294731-B1 | BISPHOSPHITE COMPOUNDS, THE METAL COMPLEXES THEREOF AND THE USE OF SAID COMPOUNDS AND COMPLEXES IN OLEFIN HYDROFORMYLATION | OXENO OLEFINCHEMIE GMBH (DE) | 2004-02-18 | — | — | EP | disclosed |
| EP-1294731-A1 | BISPHOSPHITE COMPOUNDS, THE METAL COMPLEXES THEREOF AND THE USE OF SAID COMPOUNDS AND COMPLEXES IN OLEFIN HYDROFORMYLATION | Oxeno Olefinchemie GmbH (DE) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002000670-A1 | BISPHOSPHITE COMPOUNDS, THE METAL COMPLEXES THEREOF AND THE USE OF SAID COMPOUNDS AND COMPLEXES IN OLEFIN HYDROFORMYLATION | OXENO OLEFINCHEMIE GMBH (DE) | 2002-01-03 | — | — | WO | disclosed |
| US-5998635-A | CATALYTIC CYCLIZATION AN ALDEHYDE WITH A KETENE | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1999-12-07 | — | — | US | disclosed |
| US-5391564-A | E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents | SANKYO COMPANY, LIMITED (JP) | 1995-02-21 | — | — | US | disclosed |
| US-5389626-A | 3-aryloxmethyl-cephalosporin derivatives, and their medical use | SANKYO COMPANY, LIMITED (JP) | 1995-02-14 | — | — | US | disclosed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | disclosed |
| EP-0350315-B1 | RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS | SANKYO COMPANY LIMITED (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0350315-A1 | Rhizoxin derivates and their use as anti-tumor agents | SANKYO COMPANY LIMITED (JP) | 1990-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894770-B2 | Fullerene derivative and n-type semiconductor material | SUN2, NES, L1CAM | ALDH1A1 1952/4885TSHR 2875/4885CYP3A4 2536/4885 |
| US-20180282274-A1 | FULLERENE DERIVATIVE AND n-TYPE SEMICONDUCTOR MATERIAL | SUN2, NES, L1CAM | ALDH1A1 1952/4885TSHR 2875/4885CYP3A4 2536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.